PID’de Tedavi Yaklaşımları ve Ebelik Bakımı
Referanslar
Curry A, Williams T, Penny ML. Pelvic inflammatory disease: diagnosis, management, and prevention. American Family Physician. 2019;100(6): 357-364.
Sıbıç D, Doğan RA. Pelvık İnflamatuar Hastalık ve Ebelik Yaklaşımı. Kadın Sağlığı Hemşireliği Dergisi. 2022;8(2): 104-111.
GN. Cimilli Şenocak, "Pelvik İnflamatuar Hastalık," In Karın Ağrılarına Multidisipliner Yaklaşım. Ankara: Akademisyen Kitabevi; 2019. pp.431-443.
Ford GW, Decker CF. Pelvic inflammatory disease. Disease-a-Month. 2016;62(8): 301-305. doi: 10.1016/j.disamonth.2016.03.015
Caglayan N, Kizilkaya Beji N. Pelvik İnflamatuvar Hastalık ve Hemşirelik Yaklaşımı. The Medical Journal of Okmeydani Training and Research Hospital. 2013;29(3): 154-159. doi: 10.5222/otd.2013.154
Jennings LK, Krywko DM. Pelvic inflammatory disease. In StatPearls [Internet]. StatPearls Publishing; 2022.
ACOG. Pelvic Inflammatory Disease (PID). 2019. (16/10/2023 tarihinde https://www.acog.org/en/womenshealth/faqs/pelvic-inflammatory-disease adresinden ulaşılmıştır).
Wıllke A, Özalp SS. Pelvik infeksiyonlarda antibiyotik seçimi. ANKEM Dergisi. 2011;25(4): 267-271. doi: 10.5222/ankem.2011.267
Jennings LK, Krywko DM. Pelvic Inflammatory Disease. Içinde StatPearls. StatPearls Publishing, 2020. (18/10/2023 tarihinde http://www.ncbi.nlm.nih.gov/books/NBK4999 59/ adresinden ulaşılmıştır).
CDC. Pelvic Inflammatory Disease (PID) – CDC Detailed Fact Sheet, 2022. (20/10/2023 tarihinde https://www.cdc.gov/std/pid/stdfact-pid-detailed.htm#print adresinden ulaşılmıştır).
T.C. Sağlık Bakanlığı. Pelvik İnflamatuar Hastalık (PİD), 2019. (21/10/2023 https://ezheah.saglik.gov.tr/TR,397146/pelvik -inflamatuar-hastalik-pid.html adresinden ulaşılmıştır).
Colombel JF, Shin A, Gibson PR. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2019;17(3): 380-390.e1. doi: 10.1016/j.cgh.2018.08.001
Witkin SS, Minis E, Athanasiou A, et al. Chlamydia trachomatis: Persistent Pathogen. Clinical Vaccine Immunol. 2017;24(10): e00203-17. doi: 10.1128/CVI.00203-17
Park ST, Lee SW, Kim MJ, et al. Clinical features of genital chlamydia infection in pelvic inflammatory disease. BMC Women's Health. 2017;17(1): 5. doi: 10.1186/s12905-016-0356-9
Fouks Y, Cohen Y, Tulandi T, et al. Complicated clinical course and poor reproductive outcomes of women with tubo-ovarian abscess after fertility treatments. Journal of Minimally Invasive Gynecology. 2019;26(1): 162-168. doi: 10.1016/j.jmig.2018.06.004
CDC (Centers for Disease Control and Prevention), Pelvic Inflammatory Disease. (20/10/2023 tarihinde https://www.cdc.gov/std/pid/stdfact-pid-detailed.htm#print adresinden ulaşılmıştır).
Safrai M, Rottenstreich A, Shushan A, et al. Risk factors for recurrent pelvic inflammatory disease. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020;244: 40-44. doi: 10.1016/j.ejogrb.2019.11.004
Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. American Journal of Public Health. 2004;94(8): 1327-1329. doi: 10.2105/AJPH.94.8.1327
